Platinum Investment Management LTD Arcturus Therapeutics Holdings Inc. Transaction History

Platinum Investment Management LTD

  • $2.16 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022
SELL
$34.2 - $47.56 $967,860 - $1.35 Million
-28,300 Closed
0 $0
Q2 2021

Aug 11, 2021
SELL
$25.79 - $42.11 $725,859 - $1.19 Million
-28,145 Reduced 49.86%
28,300 $958,000
Q1 2021

May 13, 2021
BUY
$38.75 - $86.92 $469,340 - $1.05 Million
12,112 Added 27.32%
56,445 $2.33 Million
Q4 2020

Feb 12, 2021
BUY
$34.61 - $123.66 $1.53 Million - $5.48 Million
44,333 New
44,333 $1.92 Million

Others Institutions Holding ARCT

# of Institutions
179
Shares Held
25.6M
Call Options Held
195K
Put Options Held
133K
View Full List

About Arcturus Therapeutics Holdings Inc.

ARCT Quotes by TradingView
  • Ticker ARCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 26,576,400
  • Market Cap $411M
  • Description
  • Arcturus Therapeutics Holdings Inc., an RNA medicines company, focuses on the development of vaccines for infectious, and liver and respiratory rare diseases in the United States. The company's development programs comprise LUNAR-OTC development program for ornithine transcarbamylase (OTC) deficiency; and LUNAR-CF program for cystic fibrosis lun...
More about ARCT
Track This Portfolio

Track Platinum Investment Management LTD Portfolio

Follow Platinum Investment Management LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Platinum Investment Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Platinum Investment Management LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email